Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-25T20:18:13.893Z Has data issue: false hasContentIssue false
  • English
  • Français

Response to Some Stimulant and Depressant Drugs of the Central Nervous System

Published online by Cambridge University Press:  08 February 2018

Edward Marley
Edward Marley*
Affiliation:
Department of Pharmacology, Royal College of Surgeons, Examination Hall, Queen Square, London, W.C.1
Get access Rights & Permissions [Opens in a new window]

Extract

Nearly one hundred years ago, Anstie (1864) wrote: “Among the too frequent instances which are to be found in medical nomenclature, of confusion and uncertainty in the application of descriptive terms, there is none, perhaps, more striking than is occupied by the words Narcotic and Stimulant.” Both classes of substance embrace drugs of antiquity. Thus of the depressants, alcohol dates from the time of the Thracian god, Dionysus, while the earliest use of stimulants such as caffeine and xanthine is lost in the obscurity of the past (Goodman and Gilman, 1955a). Even today, there exists no systematized codification of response to the two classes of drug, although it is implicitly assumed that stimulants and depressants are invariably and mutually antagonistic in their effect on the central nervous system. Advantage was therefore taken of phenomena arising during drug intoxications to categorize abnormal features in the central nervous system common to each of the two classes of intoxicant and to essay a comparison, the one with the other.

Type
Original Articles
Information
Journal of Mental Science , Volume 106 , Issue 442 , January 1960 , pp. 76 - 92
Copyright
Copyright © Royal College of Psychiatrists, 1960 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alexandroff, J., and Talpis, L., Mschr. Ohrenh., 1928, 62, 1196.Google Scholar
Alles, G. A., J. Pharmacol., 1927, 32, 121.Google Scholar
Anstie, F. E., Stimulants and Narcotics, 1864, p. 1. London: Macmillan.Google Scholar
Apfelberg, B., J. Amer. med. Ass., 1938, 110, 575.CrossRefGoogle Scholar
Baker, J. P., and Farley, J. D., Brit. med. J., 1958, ii, 1390.CrossRefGoogle Scholar
Bartholomew, A. A., and Marley, E., Psychopharmacologia, 1959, 1, 124.CrossRefGoogle Scholar
Idem , Chapell, P., Marley, E., and Chambers, J. S. W., Lancet, 1958, i, 346.Google Scholar
Bedson, H. S., ibid, 1959, i, 288.Google Scholar
Beecher, H. K., McDonouoh, F. K., and Forbes, A., J. Neurophysiol., 1939, 2, 81.CrossRefGoogle Scholar
Begg, W. G. A., and Reid, A. A., Brit. med. J., 1956, i, 946.CrossRefGoogle Scholar
Bender, M. B., and Brown, C. A., Amer. J. Ophthal., 1948, 31, 825.CrossRefGoogle Scholar
Idem , and O'Brien, F. R., ibid., 1946, 29, 1541.Google Scholar
Bethell, M. F., Brit. med. J., 1957, i, 282.Google Scholar
Bleuler, E. P., Textbook of Psychiatry, 1951, trans Brill, A. A., p. 359. Dover Publications.Google Scholar
Bonnier, P., Rev. Neurol., 1905, 13, 605. Paris.Google Scholar
Bradley, P. B., and Elkes, J., Brain, 1957, 80, 77.CrossRefGoogle ScholarPubMed
Brown, B. B., and Werner, H. N., J. Pharmacol., 1954, 110, 180.Google Scholar
Cameron, N., The Psychology of Behaviour Disorders, 1947, p. 547. New York: Houghton Mifflin.Google Scholar
Carr, R. B., Brit. med. J., 1954, i, 1476.CrossRefGoogle Scholar
Chen, G., and Bohner, B., J. Pharmacol., 1958, 123, 212.Google Scholar
Cleghorn, R. A., Amer. J. Psychiat., 1952, 108, 568.CrossRefGoogle Scholar
Cogan, D. G., Neurology of the Ocular Muscles, 1948, p. 161. Springfield, Illinois: Thomas, 1st ed.Google Scholar
Cole, J., and Glees, P., J. Ment. Sci., 1957, 103, 417.CrossRefGoogle Scholar
Connell, P. H., Amphetamine Psychosis, Maudsley Monograph No. 5, 1958a, p. 70. London: Chapman and Hall.Google Scholar
Idem , ibid., 1958b, p. 71.Google Scholar
Idem , ibid., 1958c, p. 79.Google Scholar
Idem , ibid., 1958d, p. 28.Google Scholar
Idem , ibid., 1958e, p. 53.Google Scholar
Idem , ibid., 1958f, p. 40.Google Scholar
Idem , ibid., 1958g, p. 75.Google Scholar
Idem , ibid., 1958h, p. 68.Google Scholar
Idem , ibid., 1958i, p. 88.Google Scholar
Copas, D. E., Kay, W. W., and Longman, V. H., Lancet, 1959, i, 703.CrossRefGoogle Scholar
Critchley, M., ibid., 1950, 1, 335.Google Scholar
Curran, F. J., J. nerv. ment. Dis., 1938, 88, 163.CrossRefGoogle Scholar
Idem , ibid., 1944, 100, 142.Google Scholar
Dale, H. H., and Laidlaw, H. H., J. Physiol. Lond., 1912, 45, 1.CrossRefGoogle Scholar
Davis, H., EEG. Clin. Neurophysiol., 1950, 2, 243.CrossRefGoogle Scholar
Denker, P., J. nerv. ment. Dis., 1957, 125, 427.CrossRefGoogle Scholar
Dews, P. B., Brit. J. Pharmacol., 1953, 8, 46.Google Scholar
Duke-Elder, W. S., Text-book of Ophthalmology, 1949a, vol. IV, p. 3752. London: Kimpton.Google Scholar
Idem , ibid., 1949b, p. 3745.Google Scholar
Idem , ibid., 1949c, p. 3779.Google Scholar
Idem , ibid., 1949d, p. 3781.Google Scholar
Exley, K. A., Brit. J. Pharmacol., 1954, 9, 170.Google Scholar
Fazekas, J. F., Goldraum, L. R., Koppanyi, T., and Shea, J. G., Amer. J. med. Sci., 1956, 231, 531.CrossRefGoogle Scholar
Fleckenstein, A., and Bass, H., Arch. exp. Path. Pharmak., 1953, 220, 143.CrossRefGoogle Scholar
Fleckenstein, A. and Burn, J. H., Brit. J. Pharmacol., 1953, 8, 69.Google Scholar
Freyhan, F. A., Delaware med. J., 1949, 21, 151.Google Scholar
Fullerton, A. G., J. Ment. Sci., 1956, 102, 801.CrossRefGoogle Scholar
Gershon, S., and Shaw, F. H., Brit. med. J., 1957, ii, 1509.CrossRefGoogle Scholar
Glatt, M. M., ibid., 1957, i, 460.Google Scholar
Goodman, L. S., and Gilman, A., The Pharmacological Basis of Therapeutics, 2nd ed., 1955a, p. 339. New York: Macmillan.Google Scholar
Idem , ibid., 1955b, p. 521.Google Scholar
Idem , ibid., 1955c, p. 510.Google Scholar
Guttmann, E., and Sargant, W., Brit. med. J., 1937, i, 1013.CrossRefGoogle Scholar
Hammond, P. H., Merton, P. A., and Sutton, G. G., Brit. med. Bull., 1956, 12, 214.CrossRefGoogle Scholar
Harris, T. A. B., The Mode of Action of Anaesthetics, 1951a, p. 183. Edinburgh, Livingstone.Google Scholar
Idem , ibid., 1951b, p. 196.Google Scholar
Harrison, G. A., Chemical Methods in Clinical Medicine, 1947, 3rd. ed., p. 335. London.Google Scholar
Heberden, M. B., and Cooper, W., Brit. med. J., 1957, i, 1513.CrossRefGoogle Scholar
Herman, M., and Nagler, S. H., J. nerv. ment. Dis., 1954, 120, 268.CrossRefGoogle Scholar
Himwich, H. E., “The effect of pharmacologic agents on the nervous system”, Ann. Res. Nerv. Ment. Dis., 1959, Vol. 37, p. 356. Baltimore: William and Wilkins.Google Scholar
Hinsey, J. C., Ranson, S. W., and Zeiss, F. R., J. Comp. Neurol., 1931, 53, 401.CrossRefGoogle Scholar
Hinton, J. M., J. Neurol. Neurosurg. Psychiat., 1958, 21, 301.CrossRefGoogle Scholar
Idem , and Marley, E., ibid., 1959, 22, 137.Google Scholar
Hoch, A., Rev. Neurol. Psychiat., Ednb., 1906, 4, 83.Google Scholar
Hondelink, H., Arch. exp. Path. u. Pharm., 1932, 163, 662.CrossRefGoogle Scholar
Howells, D. E., Brit. med. J., 1952, ii, 862.CrossRefGoogle Scholar
Isbell, H., Ann. intern. Med., 1950, 33, 108.Google Scholar
Idem , Altschul, S., Kornetsky, C. H., Eisenman, A. J., Flanary, H. G., and Fraser, H. F., Arch. Neuro. Psychiat. (Chicago), 1950, 64, 1.Google Scholar
Jacobsen, E., J. Pharm. Pharmacol., 1958, 10, 273.CrossRefGoogle Scholar
Klüver, H., The Brain and Human Behaviour, 1958, Vol. 36, p. 421. Baltimore: Ass. Res. Nerv. Ment. Dis., William and Wilkins.Google Scholar
Knapp, P. H., J. nerv. ment. Dis., 1952, 115, 407. Kornetsky, C. H., Arch. Neurol. Psychiat. (Chicago), 1951, 65, 557.Google Scholar
Kremer, M., Brit. med. J., 1958, ii, 121.CrossRefGoogle Scholar
Laverty, G. S., and Franks, C. M., J. Neurol. Neurosurg. Psychiat., 1956, 19, 137.CrossRefGoogle Scholar
Leake, C. D., The Amphetamines, 1958a, p. 30. Springfield, Illinois: Thomas. Idem, ibid., 1958b, p. 64.Google Scholar
Levin, M., J. Ment. Sci., 1936, 82, 1.CrossRefGoogle Scholar
Idem , Amer. J. Psychiat., 1947, 103, 229.Google Scholar
Idem , ibid., 1951, 107, 689.Google Scholar
Idem , J. Ment. Sci., 1956, 102, 619.CrossRefGoogle Scholar
Locket, S., Clinical Toxicology, 1957a, p. 351. London: Kimpton.Google Scholar
Idem , ibid., 1957b, p. 341.Google Scholar
Macht, M., Amer. J. Physiol., 1950, 163, 731.Google Scholar
Maling, H. M., and Acheson, G. H., J. Neurophysiol., 1946, 9, 379.CrossRefGoogle Scholar
Marley, E., Lancet, 1955, ii, 535.CrossRefGoogle Scholar
Idem , Brit. med. J., 1958, ii, 493.Google Scholar
Idem , Brit. J. Pharmacol., 1959a, 14, 284.Google Scholar
Idem , J. Ment. Sci., 1959b, 105, 19.CrossRefGoogle Scholar
Idem , and Bartholomew, A. A., J. Neurol. Neurosurg. Psychiat., 1958, 21, 129.Google Scholar
Idem , and Chambers, J. S. W., Brit. med. J., 1956, ii, 1467.Google Scholar
Idem , and Paton, W. D. M., Brit. J. Pharmacol., 1959, 14, 303.Google Scholar
Idem , and Vane, J. R., Brit. J. Pharmacol., 1958, 13, 364.Google Scholar
Martimor, E., Nicolas-Charles, P., and Dereux, J., Ann. méd.-psychol., 1955, 113, 353.Google Scholar
Mathias, I. G., Lancet, 1951, i, 1420.Google Scholar
Maurer, D. W., and Vogel, V. H., Narcotics and Narcotic Addiction, 1954, p. 98. Illinois: Thomas.Google Scholar
May, A. R., Brit. J. Clin. Pract., 1958, 12, 348.CrossRefGoogle Scholar
Mayer, L. L., J. Amer. med. Ass., 1939, 113, 38.CrossRefGoogle Scholar
Monroe, R. R., and Drell, H. J., ibid., 1947, 135, 909.Google Scholar
Myerson, A., and Thau, W., Arch. Neurol. Psychiat. (Chicago), 1938, 39, 780.CrossRefGoogle Scholar
Nicholls, J. G., and Qudlliam, J. P., Brit. J. Pharmacol., 1956, 11, 151.Google Scholar
Norman, J., and Shea, J. T., New Engl. J. Med., 1945, 233, 270.CrossRefGoogle Scholar
Noyes, A. P., Modern Clinical Psychiatry, 1948a, p. 63. Philadelphia: Saunders. Idem, ibid., 1948b, p. 65.Google Scholar
O'Flanagan, P. M., and Taylor, R. B., J. Ment. Sci., 1950, 96, 1033.CrossRefGoogle Scholar
Paton, W. D. M., Brit. J. Pharmacol., 1957, 12, 119.Google Scholar
Patuck, D., Brit. med. J., 1956, i, 670.CrossRefGoogle Scholar
Peoples, S. A., and Guttman, E., Lancet, 1936, i, 1107.CrossRefGoogle Scholar
Pfeiffer, C. C., Neuropharmacology, 1957, p. 267. Transactions of the Third Conference, Josiah Macy Jr. Foundation.Google Scholar
Quilliam, J. P., Brit. J. Pharmacol., 1955, 10, 133.Google Scholar
Randell, J. B., Brit. med. J., 1957, ii, 508.CrossRefGoogle Scholar
Shanson, R. ibid., 1956, i, 576.Google Scholar
Shorvon, H. J., ibid., 1945, ii, 285.Google Scholar
Silverman, M., Brit. med. J., 1959, i, 696.CrossRefGoogle Scholar
Speck, L. B., J. Pharmacol., 1957, 119, 78.Google Scholar
Spiegel, E. A., and Collins, D. A., J. Neurophysiol., 1940, 3, 59.CrossRefGoogle Scholar
Stern, R., Virchows Arkiv., 1889, 115, 14.CrossRefGoogle Scholar
Stockings, G. T., J. Ment. Sci., 1940, 86, 29.CrossRefGoogle Scholar
Tolentino, I., Psychotropic Drugs, 1957, p. 585. Amsterdam: Elsevier Publishing Co.Google Scholar
Udenfriend, S., Shore, P. A., Bogdanski, D. F., Weissbach, H., and Brodie, B. B., Recent Progress in Hormone Research, 1957, 13, 1.Google Scholar
Varley, H., Practical Clinical Biochemistry, 1954, p. 495. London: Heinemann.Google Scholar
Versteegh, C., Acta otolaryng., 1922, 4, 394.CrossRefGoogle Scholar
Wallis, G. G., McHarg, J. F., and Scott, O. C. A., Brit. med. J., 1949, ii, 1394.CrossRefGoogle Scholar
Washburne, A. C., Wisconsin med. J., 1934, 33, 746.Google Scholar
Weinstein, E. A., and Kahn, R. L., Denial of Illness, 1955, p. 123. Springfield, Illinois: Thomas.Google Scholar
White, R. P., Rinaldi, F., Himwich, H. E., J. appl. Physiol., 1956, 8, 635.CrossRefGoogle Scholar
Wolff, H. G., and Curran, D., Arch. Neurol. Psychiat. (Chicago), 1935, 33, 1175.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.